BIOSYNEX (ALBIO.PA) Stock Income Statement
Europe - EPA:ALBIO - FR0011005933 - Common Stock
0.514 EUR
-0.01 (-1.15%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 97.95M | 101.17M | 92.98M | 196.60M | 382.50M | |||
| Minority Interest Expense | -48.00K | 64.00K | -176.00K | 0.00 | N/A | |||
| Cost Of Goods | 40.34M | 43.75M | 43.85M | 94.30M | 176.10M | |||
| Gross Profit | 57.61M | 57.42M | 49.13M | 102.30M | 206.40M | |||
| Operating Expenses | 121.44M | 93.75M | 86.54M | 63.40M | 65.80M | |||
| Selling, General, and Administrative Expenses | 37.05M | 42.44M | 37.01M | 57.00M | 58.10M | |||
| Operating Income | -63.82M | -36.33M | -37.40M | 38.80M | 140.60M | |||
| Interest Income/Expense | -5.57M | -3.03M | -2.08M | -400.00K | -300.00K | |||
| Other Income/Expense | N/A | -3.19M | -982.00K | -2.80M | 400.00K | |||
| Non Recurring Items | -1.16M | -1.53M | 2.28M | -5.90M | -1.00M | |||
| Income Before Taxes | -74.14M | -44.65M | -38.16M | 29.80M | 139.60M | |||
| Income Tax | -3.36M | -1.35M | -2.56M | 8.60M | 32.90M | |||
| Net Income | -70.99M | -43.33M | -37.12M | 15.60M | 104.00M | |||
| EBITDA | -5.49M | -15.80M | -23.95M | 65.70M | 142.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.31 | -3.33 | -2.94 | 1.52 | 9.36 | |||
| Statistics | ||||||||
| Gross Profit Margin | 58.82% | 56.76% | 52.84% | 52.03% | 53.96% | |||
| Profit Margin | -72.47% | -42.83% | -39.93% | 7.93% | 27.19% | |||
| Operating Profit Margin | -65.16% | -35.91% | -40.23% | 19.74% | 36.76% | |||
All data in EUR